Omeros | Umsatzkosten



Cost Of Sales Veränderung Datum
Adma Biologics USD 54.22M 5.96M 2024-12
Alnylam Pharmaceuticals USD 71.04M 31.78M 2025-03
BioMarin Pharmaceutical USD 151.56M 15.42M 2025-03
Cytokinetics 463K 79.14M 2024-09
Dynavax Technologies USD 27.54M 14.13M 2025-03
Gilead Sciences USD 1.54B 41M 2025-03
Insmed USD 21.28M 4.87M 2025-03
Knight Therapeutics CAD 47.25M 990K 2024-09
MacroGenics USD 5.49M 3.62M 2024-12
Pacira USD 34.31M 5.58M 2025-03
Pfizer USD 2.59B 3.06B 2025-03
Sarepta Therapeutics USD 137.56M 5.26M 2025-03
United Therapeutics USD 277.5M 201.6M 2025-03
Vertex Pharmaceuticals USD 423.4M 30.8M 2024-12



Omeros Umsatzkosten - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Jul 2025.